# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-106549
Filing Date
2025-08-11
Accepted
2025-08-11 16:10:27
Documents
71
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | fgen-20250630.htm iXBRL | 10-Q | 3303886
2 | EX-10.1 | fgen-ex10_1.htm | EX-10.1 | 40068
3 | EX-31.1 | fgen-ex31_1.htm | EX-31.1 | 10221
4 | EX-31.2 | fgen-ex31_2.htm | EX-31.2 | 10215
5 | EX-32.1 | fgen-ex32_1.htm | EX-32.1 | 10202
| Complete submission text file | 0000950170-25-106549.txt |  | 11638850

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | fgen-20250630.xsd | EX-101.SCH | 1845032
73 | EXTRACTED XBRL INSTANCE DOCUMENT | fgen-20250630_htm.xml | XML | 1872704

Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 251202088
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)